Nature Study Reveals That a Single tRNA Can Reprogram Cancer Cell Fate
On October 7, a team at Fred Hutchinson Cancer Center published a study in Nature showing that tRNA₁Arg(UCU) can act like a molecular switch that influences prostate cancer cell fate. When its abundance decreases, cells can acquire treatment resistance; restoring its levels can make tumors sensitive to therapy again. The study provides evidence that an
Nature Study Reveals That a Single tRNA Can Reprogram Cancer Cell Fate Read More »